JP5921687B2 - 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類 - Google Patents

抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類 Download PDF

Info

Publication number
JP5921687B2
JP5921687B2 JP2014524410A JP2014524410A JP5921687B2 JP 5921687 B2 JP5921687 B2 JP 5921687B2 JP 2014524410 A JP2014524410 A JP 2014524410A JP 2014524410 A JP2014524410 A JP 2014524410A JP 5921687 B2 JP5921687 B2 JP 5921687B2
Authority
JP
Japan
Prior art keywords
alkyl
mmol
formula
hydrogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014524410A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014531404A (ja
Inventor
ギーエモント,ジェローム,エミリー,ジョージズ
ランコイズ,デイビッド,フランシス,アライン
モット,マガリ,マドレーヌ,シモン
コール,アニル
バレマンズ,ウェンディー,ミア,アルバート
アルノルト,エリック,ピエール,アレクサンドレ
Original Assignee
ヤンセン・サイエンシズ・アイルランド・ユーシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46650549&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5921687(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ヤンセン・サイエンシズ・アイルランド・ユーシー filed Critical ヤンセン・サイエンシズ・アイルランド・ユーシー
Publication of JP2014531404A publication Critical patent/JP2014531404A/ja
Application granted granted Critical
Publication of JP5921687B2 publication Critical patent/JP5921687B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2014524410A 2011-08-10 2012-08-10 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類 Expired - Fee Related JP5921687B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11177119 2011-08-10
EP11177119.2 2011-08-10
PCT/EP2012/065733 WO2013021054A1 (en) 2011-08-10 2012-08-10 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016079689A Division JP2016190843A (ja) 2011-08-10 2016-04-12 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類

Publications (2)

Publication Number Publication Date
JP2014531404A JP2014531404A (ja) 2014-11-27
JP5921687B2 true JP5921687B2 (ja) 2016-05-24

Family

ID=46650549

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014524410A Expired - Fee Related JP5921687B2 (ja) 2011-08-10 2012-08-10 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類
JP2016079689A Withdrawn JP2016190843A (ja) 2011-08-10 2016-04-12 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016079689A Withdrawn JP2016190843A (ja) 2011-08-10 2016-04-12 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類

Country Status (24)

Country Link
US (7) US8906923B2 (OSRAM)
EP (1) EP2742045B1 (OSRAM)
JP (2) JP5921687B2 (OSRAM)
KR (1) KR101996862B1 (OSRAM)
CN (2) CN105461684B (OSRAM)
AR (1) AR087508A1 (OSRAM)
AU (1) AU2012293621B2 (OSRAM)
BR (1) BR112014003063B1 (OSRAM)
CA (1) CA2842518C (OSRAM)
CL (1) CL2014000289A1 (OSRAM)
DK (1) DK2742045T3 (OSRAM)
EA (1) EA201490438A1 (OSRAM)
ES (1) ES2721658T3 (OSRAM)
HU (1) HUE042978T2 (OSRAM)
IL (1) IL230549A (OSRAM)
JO (1) JO3611B1 (OSRAM)
MX (1) MX348128B (OSRAM)
PE (1) PE20141410A1 (OSRAM)
PH (1) PH12014500317A1 (OSRAM)
TR (1) TR201905537T4 (OSRAM)
TW (1) TWI568731B (OSRAM)
UA (1) UA111210C2 (OSRAM)
UY (1) UY34253A (OSRAM)
WO (1) WO2013021054A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016190843A (ja) * 2011-08-10 2016-11-10 ヤンセン・サイエンシズ・アイルランド・ユーシー 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2881681T3 (es) 2011-08-10 2021-11-30 Janssen Sciences Ireland Unlimited Co 3,4-Dihidro-1H-[1,8]naftiridinonas sustituidas con piperidinilo antibacterianas
WO2014023814A1 (en) * 2012-08-10 2014-02-13 Janssen R&D Ireland New antibacterial compounds
US9540324B2 (en) 2013-09-26 2017-01-10 Luc Therapeutics, Inc. Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
JO3579B1 (ar) * 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
SMT201900517T1 (it) 2017-03-20 2019-11-13 Forma Therapeutics Inc Composizioni di pirrolopirrolo come attivatori di piruvato chinasi (pkr)
WO2019177975A1 (en) 2018-03-12 2019-09-19 The Board Of Trustees Of The University Of Illinois Antibiotics effective for gram-negative pathogens
CN113226356B (zh) 2018-09-19 2025-03-04 诺沃挪第克健康护理股份公司 活化丙酮酸激酶r
US20200129485A1 (en) 2018-09-19 2020-04-30 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
BR112021009106A2 (pt) * 2018-11-12 2021-08-10 Debiopharm International S.A. compostos antibióticos, métodos de fabricação dos mesmos, composições farmacêuticas que os contêm e seus usos
CN114615977B (zh) 2019-09-19 2025-01-14 诺沃挪第克健康护理股份公司 丙酮酸激酶r(pkr)活化组合物
JP2024509998A (ja) * 2021-03-17 2024-03-05 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗菌化合物
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215123A (en) * 1979-05-07 1980-07-29 American Home Products Corporation Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
JP4961084B2 (ja) 1999-10-08 2012-06-27 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Fabi阻害剤
EP1225894B1 (en) 1999-10-08 2006-07-05 Affinium Pharmaceuticals, Inc. Fab i inhibitors
PE20010635A1 (es) 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
DK1560584T3 (da) 2001-04-06 2009-05-18 Affinium Pharm Inc Fab I inhibitorer
KR101299399B1 (ko) * 2004-06-04 2013-08-22 아피늄 파마슈티컬스, 인크. 치료제, 및 그의 제조 및 사용 방법
US7732612B2 (en) 2004-09-09 2010-06-08 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
US7973060B2 (en) 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
EP2125802A4 (en) * 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
US8846711B2 (en) 2009-11-18 2014-09-30 Fab Pharma S.A.S. Heterocyclic acrylamides and their use as pharmaceuticals
US8766017B2 (en) 2011-07-29 2014-07-01 Eastman Chemical Company Integrated process for the preparation of 1,4-cyclohexanedimethanol from terephthalic acid
CA2843643A1 (en) 2011-07-29 2013-02-07 The Children's Hospital Of Philadelphia Compositions and methods for the treatment of hiv
ES2881681T3 (es) 2011-08-10 2021-11-30 Janssen Sciences Ireland Unlimited Co 3,4-Dihidro-1H-[1,8]naftiridinonas sustituidas con piperidinilo antibacterianas
AU2012293618B2 (en) 2011-08-10 2017-04-20 Janssen Sciences Ireland Uc Antibacterial homopiperidinyl substituted 3,4 dihydro 1H (1,8)naphthyridinones
JO3611B1 (ar) * 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016190843A (ja) * 2011-08-10 2016-11-10 ヤンセン・サイエンシズ・アイルランド・ユーシー 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類

Also Published As

Publication number Publication date
US10501463B2 (en) 2019-12-10
AU2012293621B2 (en) 2016-07-21
US20160194324A1 (en) 2016-07-07
IL230549A (en) 2017-07-31
JP2016190843A (ja) 2016-11-10
BR112014003063A2 (pt) 2017-02-21
HK1223352A1 (zh) 2017-07-28
EP2742045B1 (en) 2019-01-23
UA111210C2 (uk) 2016-04-11
TWI568731B (zh) 2017-02-01
US20190084982A1 (en) 2019-03-21
CL2014000289A1 (es) 2014-07-11
TW201313714A (zh) 2013-04-01
DK2742045T3 (en) 2019-04-23
PH12014500317A1 (en) 2014-04-14
US10526331B2 (en) 2020-01-07
AU2012293621A1 (en) 2014-02-13
US20140171451A1 (en) 2014-06-19
US20150080413A1 (en) 2015-03-19
US20180105525A1 (en) 2018-04-19
US9290493B2 (en) 2016-03-22
US9884864B2 (en) 2018-02-06
CN103874698B (zh) 2016-03-23
EA201490438A1 (ru) 2014-06-30
HK1199243A1 (zh) 2015-06-26
MX348128B (es) 2017-05-26
CN103874698A (zh) 2014-06-18
KR101996862B1 (ko) 2019-07-05
US10155759B2 (en) 2018-12-18
JP2014531404A (ja) 2014-11-27
PE20141410A1 (es) 2014-10-13
KR20140072034A (ko) 2014-06-12
ES2721658T3 (es) 2019-08-02
US8906923B2 (en) 2014-12-09
JO3611B1 (ar) 2020-08-27
US20170174683A1 (en) 2017-06-22
IL230549A0 (en) 2014-03-31
EP2742045A1 (en) 2014-06-18
US9617262B2 (en) 2017-04-11
AR087508A1 (es) 2014-03-26
TR201905537T4 (tr) 2019-05-21
CN105461684B (zh) 2018-09-25
HUE042978T2 (hu) 2019-07-29
WO2013021054A1 (en) 2013-02-14
US20190194194A1 (en) 2019-06-27
CA2842518A1 (en) 2013-02-14
NZ620212A (en) 2015-10-30
UY34253A (es) 2013-02-28
BR112014003063B1 (pt) 2020-11-17
CN105461684A (zh) 2016-04-06
CA2842518C (en) 2019-07-23
MX2014001600A (es) 2014-04-25

Similar Documents

Publication Publication Date Title
JP5921687B2 (ja) 抗菌性シクロペンタ[c]ピロール置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類
JP6294822B2 (ja) 抗菌性ピペリジニル置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類
JP6521631B2 (ja) 抗菌性ホモピペリジニル置換3,4−ジヒドロ−1h−[1,8]−ナフチリジノン類
HK1223352B (zh) 抗菌的环戊二烯并[c]吡咯取代的3,4-二氢-1h-[1,8]萘啶酮
EA043636B1 (ru) АНТИБАКТЕРИАЛЬНЫЕ 3,4-ДИГИДРО-1Н-[1,8]НАФТИРИДИНОНЫ, ЗАМЕЩЕННЫЕ ЦИКЛОПЕНТА[с]ПИРРОЛОМ

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150807

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20150814

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160225

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160315

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160412

R150 Certificate of patent or registration of utility model

Ref document number: 5921687

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees